This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Key Event Title
Protein Adduct Formation
|Level of Biological Organization
Key Event Components
Key Event Overview
AOPs Including This Key Event
|Role of event in AOP
|Point of Contact
|CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|Brendan Ferreri-Hanberry (send email)
|Under development: Not open for comment. Do not cite
Key Event Description
Reactive chemicals or metabolites can interact with proteins present in any cell type which occur at the molecular level. The electrophilic chemicals react with the nucleophilic parts of proteins, forming a covalent bond. When proteins are in their original shape they can function properly, when this is not the case the protein loses its function. These are unspecific proteins which are altered in shape due to the covalent binding of chemicals.
How It Is Measured or Detected
The determination of protein adducts can be done, but since some chemicals induce protein adducts at low abundance it is hard to measure. A new technique is developed to overcome the problem of the low abundance. A drug is labelled with a biotin affinity tag, which than can react with proteins and bind covalently. After incubation with several proteins the drugs attached to the proteins are separated from the rest of the free proteins with the use of the tag. Next the proteins which are altered by the drug can be identified with proteomics. A LC/MS/MS technique is used. A problem which can occur, is that the use of a tag can influence the binding profile of the drug. Another possibility is the use of 2D gel-electrophoresis and tandem mass spectrometry based proteomics. Proteins are purified from cells after incubation with a drug. With 2D gel-electrophoresis the proteins are separated, afterwards the spots of interest are identified with tandem mass spectrometry.
Domain of Applicability
LoPachin, R. M. & DeCaprio, A. P. Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicological Sciences 86, 214–225 (2005)
Gan, J., Zhang, H. & Humphreys, W. G. Drug-Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization. Chemical Research in Toxicology 29, 2040–2057 (2016)